Rockwell Medical Net Worth

Rockwell Medical Net Worth Breakdown

  RMTI
The net worth of Rockwell Medical is the difference between its total assets and liabilities. Rockwell Medical's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Rockwell Medical's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Rockwell Medical's net worth can be used as a measure of its financial health and stability which can help investors to decide if Rockwell Medical is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Rockwell Medical stock.

Rockwell Medical Net Worth Analysis

Rockwell Medical's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Rockwell Medical's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Rockwell Medical's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Rockwell Medical's net worth analysis. One common approach is to calculate Rockwell Medical's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Rockwell Medical's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Rockwell Medical's net worth. This approach calculates the present value of Rockwell Medical's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Rockwell Medical's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Rockwell Medical's net worth. This involves comparing Rockwell Medical's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Rockwell Medical's net worth relative to its peers.

Enterprise Value

41.5 Million

To determine if Rockwell Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Rockwell Medical's net worth research are outlined below:
Rockwell Medical generated a negative expected return over the last 90 days
Rockwell Medical may become a speculative penny stock
Rockwell Medical has high historical volatility and very poor performance
Rockwell Medical has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 83.61 M. Net Loss for the year was (8.44 M) with profit before overhead, payroll, taxes, and interest of 16.72 M.
Rockwell Medical currently holds about 27.56 M in cash with (9.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.37, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Rockwell Medical has a frail financial position based on the latest SEC disclosures
Roughly 13.0% of the company outstanding shares are owned by corporate insiders
Latest headline from gurufocus.com: ARIA Cybersecurity Partners with Rexel to Protect Rockwell Automation Customers from Dangerous ...

Rockwell Medical Quarterly Good Will

921,000

Rockwell Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Rockwell Medical. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Rockwell Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
4th of April 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Know Rockwell Medical's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Rockwell Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Rockwell Medical backward and forwards among themselves. Rockwell Medical's institutional investor refers to the entity that pools money to purchase Rockwell Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Morgan Stanley - Brokerage Accounts2024-12-31
97.9 K
Jpmorgan Chase & Co2024-09-30
94.1 K
Goldman Sachs Group Inc2024-12-31
82.7 K
Corsair Capital Management Llc2024-12-31
75 K
Millennium Management Llc2024-12-31
74.3 K
Perkins Capital Management Inc2024-12-31
74 K
Dimensional Fund Advisors, Inc.2024-12-31
71.6 K
Northern Trust Corp2024-12-31
63.4 K
Hightower Advisors, Llc2024-12-31
57.4 K
Armistice Capital, Llc2024-12-31
M
Vanguard Group Inc2024-12-31
1.2 M
Note, although Rockwell Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Rockwell Medical's market capitalization trends

The company currently falls under 'Micro-Cap' category with a current market capitalization of 54.36 M.

Market Cap

37.69 Million

Project Rockwell Medical's profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.24)(0.25)
Return On Capital Employed(0.22)(0.23)
Return On Assets(0.19)(0.20)
Return On Equity(0.46)(0.48)
The company has Profit Margin (PM) of (0.01) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.07 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.07.
When accessing Rockwell Medical's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Rockwell Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Rockwell Medical's profitability and make more informed investment decisions.

Evaluate Rockwell Medical's management efficiency

The current Return On Tangible Assets is estimated to decrease to -0.25. The current Return On Capital Employed is estimated to decrease to -0.23. As of now, Rockwell Medical's Other Assets are increasing as compared to previous years. The Rockwell Medical's current Net Tangible Assets is estimated to increase to about 20.7 M, while Total Assets are projected to decrease to under 37.3 M. Rockwell Medical's management efficiency ratios could be used to measure how well Rockwell Medical manages its routine affairs as well as how well it operates its assets and liabilities.
Last ReportedProjected for Next Year
Book Value Per Share 1.05  1.00 
Tangible Book Value Per Share 0.47  0.45 
Enterprise Value Over EBITDA(11.89)(12.49)
Price Book Value Ratio 1.86  1.77 
Enterprise Value Multiple(11.89)(12.49)
Price Fair Value 1.86  1.77 
Enterprise Value43.7 M41.5 M
Understanding the operational decisions made by Rockwell Medical management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Enterprise Value Revenue
0.5042
Revenue
98.9 M
Quarterly Revenue Growth
0.191
Revenue Per Share
3.296
Return On Equity
(0.05)
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Rockwell Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Rockwell Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Rockwell Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Rockwell Medical time-series forecasting models is one of many Rockwell Medical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Rockwell Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Rockwell Medical Earnings per Share Projection vs Actual

Rockwell Medical Corporate Management

Megan TimminsChief VPProfile
David KullPrincipal Accounting OfficerProfile
Jason FinkelsteinInvestor RepresentativeProfile
Marc MDChief OfficerProfile
Jesse NeriSenior FinanceProfile
When determining whether Rockwell Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Rockwell Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Rockwell Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Rockwell Medical Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rockwell Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more detail on how to invest in Rockwell Stock please use our How to Invest in Rockwell Medical guide.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rockwell Medical. If investors know Rockwell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rockwell Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.04)
Revenue Per Share
3.296
Quarterly Revenue Growth
0.191
Return On Assets
0.0066
Return On Equity
(0.05)
The market value of Rockwell Medical is measured differently than its book value, which is the value of Rockwell that is recorded on the company's balance sheet. Investors also form their own opinion of Rockwell Medical's value that differs from its market value or its book value, called intrinsic value, which is Rockwell Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rockwell Medical's market value can be influenced by many factors that don't directly affect Rockwell Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rockwell Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Rockwell Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rockwell Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.